Published every week since 2010, Prostate Cell News compiles top scientific journal articles covering the characterization, behavior, and culturing prostate cells. Additionally, our editorial team curates the latest press releases, technical advances, jobs, and events relevant to the prostate cell research community. Prostate Cell News saves scientists valuable time while keeping them informed in their field, facilitating the rapid exchange of cutting edge research updates and science news.
Angeles, A. K., Heckmann, D., Flosdorf, N., Duensing, S., & Sultmann, H. (2020). The ERG-regulated LINC00920 promotes prostate cancer cell survival via the 14-3-3&epsilon;- FOXO pathway. Molecular Cancer Research. https://doi.org/10.1158/1541-7786.MCR-20-0021Cite
The anticancer potential of the fractions was evaluated in vitro using different cancer cell lines: human colorectal carcinoma and PC-3. Fibroblast-like cells of L929 obtained from subcutaneous adipose tissue of mouse were used as normal cells.
Chilczuk, B., Marciniak, B., Stochmal, A., Pecio, Ł., Kontek, R., Jackowska, I., & Materska, M. (2020). Anticancer Potential and Capsianosides Identification in Lipophilic Fraction of Sweet Pepper (Capsicum annuum L.). Molecules, 25(13), 3097. https://doi.org/10.3390/molecules25133097Cite
Lovnicki, J. M., Gan, Y., Feng, T., Li, Y., Xie, N., Ho, C.-H., … Dong, X. (2020). LIN28B promotes the development of neuroendocrine prostate cancer. The Journal of Clinical Investigation. https://doi.org/10.1172/JCI135373Cite
Zhan, B., Huang, L., Chen, Y., Ye, W., Li, J., Chen, J., … Jiang, W. (n.d.). miR-196a-mediated downregulation of p27kip1 protein promotes prostate cancer proliferation and relates to biochemical recurrence after radical prostatectomy. The Prostate, n/a(n/a). https://doi.org/10.1002/pros.24036Cite
Qin, C., Sheng, Z., Huang, X., Tang, J., Liu, Y., Xu, T., & Qiu, X. (n.d.). Cancer-driven IgG promotes the development of prostate cancer though the SOX2-CIgG pathway. The Prostate, n/a(n/a). https://doi.org/10.1002/pros.24042Cite
RefleXion Medical and Telix Pharmaceuticals Limited announced a strategic collaboration to investigate the clinical utility of combining the companies’ technologies to improve treatment for high-risk or recurrent prostate and aggressive kidney cancers.
Researchers reported that the expression of thioredoxin interacting protein (TXNIP) was significantly decreased in prostate cancer and associated with clinicopathological features. Overexpression of TXNIP could significantly inhibit PC‐3 cells proliferation, migration, invasion and glucose uptake.
Xie, M., Xie, R., Xie, S., Wu, Y., Wang, W., Li, X., … Pan, T. (n.d.). Thioredoxin interacting protein (TXNIP) acts as a tumor suppressor in human prostate cancer. Cell Biology International, n/a(n/a). https://doi.org/10.1002/cbin.11418Cite
The CCK-8 experiment demonstrated that CPT1B overexpression in C4-2 cells did not significantly increase the ability of enzalutamide resistance. However, overexpression of CPT1B in C4-2R cells significantly increased the enzalutamide resistance.
Abudurexiti, M., Zhu, W., Wang, Y., Wang, J., Xu, W., Huang, Y., … Ye, D. (n.d.). Targeting CPT1B as a potential therapeutic strategy in castration-resistant and enzalutamide-resistant prostate cancer. The Prostate, n/a(n/a). https://doi.org/10.1002/pros.24027Cite
International students completing their medical and doctoral degrees in the US are wrestling with frustration and uncertainty following the release of federal rules this week that could bar them from staying in the country.
Chakravarty, D., Nair, S. S., Hammouda, N., Ratnani, P., Gharib, Y., Wagaskar, V., … Tewari, A. K. (2020). Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer. Communications Biology, 3(1), 1–12. https://doi.org/10.1038/s42003-020-1088-9Cite
Flynn, L., Barr, M. P., Baird, A.-M., Smyth, P., Casey, O. M., Blackshields, G., … Finn, S. P. (2020). Prostate cancer-derived holoclones: a novel and effective model for evaluating cancer stemness. Scientific Reports, 10(1), 11329. https://doi.org/10.1038/s41598-020-68187-9Cite
A new US immigration policy, which threatens to revoke visas for certain international students if they are not taking in-person classes, is stirring panic and confusion and causing some universities to push back with lawsuits.